Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes

Single-walled carbon nanotubes (SWCNT) have been introduced into a large number of new technologies and consumer products. The combination of their exceptional features with very broad applications raised concerns regarding their potential health effects. The prime target for SWCNT toxicity is belie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology and applied pharmacology 2008-09, Vol.231 (2), p.235-240
Hauptverfasser: Shvedova, A.A., Kisin, E.R., Murray, A.R., Kommineni, C., Castranova, V., Fadeel, B., Kagan, V.E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 240
container_issue 2
container_start_page 235
container_title Toxicology and applied pharmacology
container_volume 231
creator Shvedova, A.A.
Kisin, E.R.
Murray, A.R.
Kommineni, C.
Castranova, V.
Fadeel, B.
Kagan, V.E.
description Single-walled carbon nanotubes (SWCNT) have been introduced into a large number of new technologies and consumer products. The combination of their exceptional features with very broad applications raised concerns regarding their potential health effects. The prime target for SWCNT toxicity is believed to be the lung where exposure may occur through inhalation, particularly in occupational settings. Our previous work has demonstrated that SWCNT cause robust inflammatory responses in rodents with very early termination of the acute phase and rapid onset of chronic fibrosis. Timely elimination of polymorphonuclear neutrophils (PMNs) through apoptosis and their subsequent clearance by macrophages is a necessary stage in the resolution of pulmonary inflammation whereby NADPH oxidase contributes to control of apoptotic cell death and clearance of PMNs. Thus, we hypothesized that NADPH oxidase may be an important regulator of the transition from the acute inflammation to the chronic fibrotic stage in response to SWCNT. To experimentally address the hypothesis, we employed NADPH oxidase-deficient mice which lack the gp91 phox subunit of the enzymatic complex. We found that NADPH oxidase null mice responded to SWCNT exposure with a marked accumulation of PMNs and elevated levels of apoptotic cells in the lungs, production of pro-inflammatory cytokines, decreased production of the anti-inflammatory and pro-fibrotic cytokine, TGF-β, and significantly lower levels of collagen deposition, as compared to C57BL/6 control mice. These results demonstrate a role for NADPH oxidase-derived reactive oxygen species in determining course of pulmonary response to SWCNT.
doi_str_mv 10.1016/j.taap.2008.04.018
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_563968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X08001890</els_id><sourcerecordid>19714208</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-7fafd40ade518ba8af22560213c81e2b7e7a44710d6a640559d3676ef658a86a3</originalsourceid><addsrcrecordid>eNp9kc-O0zAQxiMEYsvCC3BAlhDckrUT20klLkv5sytVwAEkbtbEnlCX1A62A8s78NA4tCw3TrbGv_k833xF8ZjRilEmL_ZVApiqmtKuoryirLtTrBhdy5I2TXO3WFHKWZlfP58VD2LcU0rXnLP7xRnrRMOlaFbFr2unA0JEQ0Dr-TCPkKx3xA_E4ZyCn3Z2jAScIQb_koPtg482EutI2iEZZ_dl6Xh3-erDFfE31mSsNDhYbdElshHty-2FJAerkeDN5BeR5ImG0Oe_HDif5h7jw-LeAGPER6fzvPj05vXHzVW5ff_2enO5LbXgbSrbAQbDKRgUrOuhg6GuhaQ1a3THsO5bbIHzllEjQXIqxNo0spU4SNFBJ6E5L8qjbvyB09yrKdgDhJ_Kg1Wn0td8QyVks5Zd5p8eeR9TrmubUO-0dw51UjVjPO9VZur5kZqC_zZjTOpgo8ZxBId-joqtW8ZrusjVR1DnLcaAw-0AjKolWbVXS7JqSVZRrnKyuenJSX3uD2j-tZyizMCzEwBRwzgEcNrGW66msmnFHzMvjhzmDX-3GBZD6DQaGxY_xtv_zfEbkkfCXg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19714208</pqid></control><display><type>article</type><title>Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shvedova, A.A. ; Kisin, E.R. ; Murray, A.R. ; Kommineni, C. ; Castranova, V. ; Fadeel, B. ; Kagan, V.E.</creator><creatorcontrib>Shvedova, A.A. ; Kisin, E.R. ; Murray, A.R. ; Kommineni, C. ; Castranova, V. ; Fadeel, B. ; Kagan, V.E.</creatorcontrib><description>Single-walled carbon nanotubes (SWCNT) have been introduced into a large number of new technologies and consumer products. The combination of their exceptional features with very broad applications raised concerns regarding their potential health effects. The prime target for SWCNT toxicity is believed to be the lung where exposure may occur through inhalation, particularly in occupational settings. Our previous work has demonstrated that SWCNT cause robust inflammatory responses in rodents with very early termination of the acute phase and rapid onset of chronic fibrosis. Timely elimination of polymorphonuclear neutrophils (PMNs) through apoptosis and their subsequent clearance by macrophages is a necessary stage in the resolution of pulmonary inflammation whereby NADPH oxidase contributes to control of apoptotic cell death and clearance of PMNs. Thus, we hypothesized that NADPH oxidase may be an important regulator of the transition from the acute inflammation to the chronic fibrotic stage in response to SWCNT. To experimentally address the hypothesis, we employed NADPH oxidase-deficient mice which lack the gp91 phox subunit of the enzymatic complex. We found that NADPH oxidase null mice responded to SWCNT exposure with a marked accumulation of PMNs and elevated levels of apoptotic cells in the lungs, production of pro-inflammatory cytokines, decreased production of the anti-inflammatory and pro-fibrotic cytokine, TGF-β, and significantly lower levels of collagen deposition, as compared to C57BL/6 control mice. These results demonstrate a role for NADPH oxidase-derived reactive oxygen species in determining course of pulmonary response to SWCNT.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1016/j.taap.2008.04.018</identifier><identifier>PMID: 18534653</identifier><identifier>CODEN: TXAPA9</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>60 APPLIED LIFE SCIENCES ; Animals ; APOPTOSIS ; Apoptosis - drug effects ; Biological and medical sciences ; CARBON ; COLLAGEN ; Collagen - drug effects ; Collagen - metabolism ; Cytokines - drug effects ; Cytokines - metabolism ; Drug toxicity and drugs side effects treatment ; FIBROSIS ; Fibrosis - etiology ; Fibrosis - metabolism ; INFLAMMATION ; Inflammation - etiology ; Inflammation - pathology ; INHALATION ; INJURIES ; Lung - drug effects ; Lung - pathology ; Lung disease ; Lung Diseases - etiology ; Lung Diseases - pathology ; LUNGS ; LYMPHOKINES ; MACROPHAGES ; Male ; Medical sciences ; MICE ; Mice, Inbred C57BL ; Miscellaneous (drug allergy, mutagens, teratogens...) ; NADPH Oxidases - genetics ; NADPH Oxidases - metabolism ; Nanoparticles ; NANOTUBES ; Nanotubes, Carbon - toxicity ; NEUTROPHILS ; Neutrophils - drug effects ; Neutrophils - metabolism ; Occupational Exposure - adverse effects ; OXIDASES ; OXIDATION ; Oxidative enzymes ; Pharmacology. Drug treatments ; Pulmonary injury ; TOXICITY ; Transforming Growth Factor beta - drug effects ; Transforming Growth Factor beta - metabolism</subject><ispartof>Toxicology and applied pharmacology, 2008-09, Vol.231 (2), p.235-240</ispartof><rights>2008 Elsevier Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-7fafd40ade518ba8af22560213c81e2b7e7a44710d6a640559d3676ef658a86a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041008X08001890$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20637568$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18534653$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21140946$$D View this record in Osti.gov$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:117627546$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Shvedova, A.A.</creatorcontrib><creatorcontrib>Kisin, E.R.</creatorcontrib><creatorcontrib>Murray, A.R.</creatorcontrib><creatorcontrib>Kommineni, C.</creatorcontrib><creatorcontrib>Castranova, V.</creatorcontrib><creatorcontrib>Fadeel, B.</creatorcontrib><creatorcontrib>Kagan, V.E.</creatorcontrib><title>Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>Single-walled carbon nanotubes (SWCNT) have been introduced into a large number of new technologies and consumer products. The combination of their exceptional features with very broad applications raised concerns regarding their potential health effects. The prime target for SWCNT toxicity is believed to be the lung where exposure may occur through inhalation, particularly in occupational settings. Our previous work has demonstrated that SWCNT cause robust inflammatory responses in rodents with very early termination of the acute phase and rapid onset of chronic fibrosis. Timely elimination of polymorphonuclear neutrophils (PMNs) through apoptosis and their subsequent clearance by macrophages is a necessary stage in the resolution of pulmonary inflammation whereby NADPH oxidase contributes to control of apoptotic cell death and clearance of PMNs. Thus, we hypothesized that NADPH oxidase may be an important regulator of the transition from the acute inflammation to the chronic fibrotic stage in response to SWCNT. To experimentally address the hypothesis, we employed NADPH oxidase-deficient mice which lack the gp91 phox subunit of the enzymatic complex. We found that NADPH oxidase null mice responded to SWCNT exposure with a marked accumulation of PMNs and elevated levels of apoptotic cells in the lungs, production of pro-inflammatory cytokines, decreased production of the anti-inflammatory and pro-fibrotic cytokine, TGF-β, and significantly lower levels of collagen deposition, as compared to C57BL/6 control mice. These results demonstrate a role for NADPH oxidase-derived reactive oxygen species in determining course of pulmonary response to SWCNT.</description><subject>60 APPLIED LIFE SCIENCES</subject><subject>Animals</subject><subject>APOPTOSIS</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>CARBON</subject><subject>COLLAGEN</subject><subject>Collagen - drug effects</subject><subject>Collagen - metabolism</subject><subject>Cytokines - drug effects</subject><subject>Cytokines - metabolism</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>FIBROSIS</subject><subject>Fibrosis - etiology</subject><subject>Fibrosis - metabolism</subject><subject>INFLAMMATION</subject><subject>Inflammation - etiology</subject><subject>Inflammation - pathology</subject><subject>INHALATION</subject><subject>INJURIES</subject><subject>Lung - drug effects</subject><subject>Lung - pathology</subject><subject>Lung disease</subject><subject>Lung Diseases - etiology</subject><subject>Lung Diseases - pathology</subject><subject>LUNGS</subject><subject>LYMPHOKINES</subject><subject>MACROPHAGES</subject><subject>Male</subject><subject>Medical sciences</subject><subject>MICE</subject><subject>Mice, Inbred C57BL</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>NADPH Oxidases - genetics</subject><subject>NADPH Oxidases - metabolism</subject><subject>Nanoparticles</subject><subject>NANOTUBES</subject><subject>Nanotubes, Carbon - toxicity</subject><subject>NEUTROPHILS</subject><subject>Neutrophils - drug effects</subject><subject>Neutrophils - metabolism</subject><subject>Occupational Exposure - adverse effects</subject><subject>OXIDASES</subject><subject>OXIDATION</subject><subject>Oxidative enzymes</subject><subject>Pharmacology. Drug treatments</subject><subject>Pulmonary injury</subject><subject>TOXICITY</subject><subject>Transforming Growth Factor beta - drug effects</subject><subject>Transforming Growth Factor beta - metabolism</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc-O0zAQxiMEYsvCC3BAlhDckrUT20klLkv5sytVwAEkbtbEnlCX1A62A8s78NA4tCw3TrbGv_k833xF8ZjRilEmL_ZVApiqmtKuoryirLtTrBhdy5I2TXO3WFHKWZlfP58VD2LcU0rXnLP7xRnrRMOlaFbFr2unA0JEQ0Dr-TCPkKx3xA_E4ZyCn3Z2jAScIQb_koPtg482EutI2iEZZ_dl6Xh3-erDFfE31mSsNDhYbdElshHty-2FJAerkeDN5BeR5ImG0Oe_HDif5h7jw-LeAGPER6fzvPj05vXHzVW5ff_2enO5LbXgbSrbAQbDKRgUrOuhg6GuhaQ1a3THsO5bbIHzllEjQXIqxNo0spU4SNFBJ6E5L8qjbvyB09yrKdgDhJ_Kg1Wn0td8QyVks5Zd5p8eeR9TrmubUO-0dw51UjVjPO9VZur5kZqC_zZjTOpgo8ZxBId-joqtW8ZrusjVR1DnLcaAw-0AjKolWbVXS7JqSVZRrnKyuenJSX3uD2j-tZyizMCzEwBRwzgEcNrGW66msmnFHzMvjhzmDX-3GBZD6DQaGxY_xtv_zfEbkkfCXg</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Shvedova, A.A.</creator><creator>Kisin, E.R.</creator><creator>Murray, A.R.</creator><creator>Kommineni, C.</creator><creator>Castranova, V.</creator><creator>Fadeel, B.</creator><creator>Kagan, V.E.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U2</scope><scope>7U7</scope><scope>C1K</scope><scope>OTOTI</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20080901</creationdate><title>Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes</title><author>Shvedova, A.A. ; Kisin, E.R. ; Murray, A.R. ; Kommineni, C. ; Castranova, V. ; Fadeel, B. ; Kagan, V.E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-7fafd40ade518ba8af22560213c81e2b7e7a44710d6a640559d3676ef658a86a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>60 APPLIED LIFE SCIENCES</topic><topic>Animals</topic><topic>APOPTOSIS</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>CARBON</topic><topic>COLLAGEN</topic><topic>Collagen - drug effects</topic><topic>Collagen - metabolism</topic><topic>Cytokines - drug effects</topic><topic>Cytokines - metabolism</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>FIBROSIS</topic><topic>Fibrosis - etiology</topic><topic>Fibrosis - metabolism</topic><topic>INFLAMMATION</topic><topic>Inflammation - etiology</topic><topic>Inflammation - pathology</topic><topic>INHALATION</topic><topic>INJURIES</topic><topic>Lung - drug effects</topic><topic>Lung - pathology</topic><topic>Lung disease</topic><topic>Lung Diseases - etiology</topic><topic>Lung Diseases - pathology</topic><topic>LUNGS</topic><topic>LYMPHOKINES</topic><topic>MACROPHAGES</topic><topic>Male</topic><topic>Medical sciences</topic><topic>MICE</topic><topic>Mice, Inbred C57BL</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>NADPH Oxidases - genetics</topic><topic>NADPH Oxidases - metabolism</topic><topic>Nanoparticles</topic><topic>NANOTUBES</topic><topic>Nanotubes, Carbon - toxicity</topic><topic>NEUTROPHILS</topic><topic>Neutrophils - drug effects</topic><topic>Neutrophils - metabolism</topic><topic>Occupational Exposure - adverse effects</topic><topic>OXIDASES</topic><topic>OXIDATION</topic><topic>Oxidative enzymes</topic><topic>Pharmacology. Drug treatments</topic><topic>Pulmonary injury</topic><topic>TOXICITY</topic><topic>Transforming Growth Factor beta - drug effects</topic><topic>Transforming Growth Factor beta - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shvedova, A.A.</creatorcontrib><creatorcontrib>Kisin, E.R.</creatorcontrib><creatorcontrib>Murray, A.R.</creatorcontrib><creatorcontrib>Kommineni, C.</creatorcontrib><creatorcontrib>Castranova, V.</creatorcontrib><creatorcontrib>Fadeel, B.</creatorcontrib><creatorcontrib>Kagan, V.E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>OSTI.GOV</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shvedova, A.A.</au><au>Kisin, E.R.</au><au>Murray, A.R.</au><au>Kommineni, C.</au><au>Castranova, V.</au><au>Fadeel, B.</au><au>Kagan, V.E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2008-09-01</date><risdate>2008</risdate><volume>231</volume><issue>2</issue><spage>235</spage><epage>240</epage><pages>235-240</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><coden>TXAPA9</coden><abstract>Single-walled carbon nanotubes (SWCNT) have been introduced into a large number of new technologies and consumer products. The combination of their exceptional features with very broad applications raised concerns regarding their potential health effects. The prime target for SWCNT toxicity is believed to be the lung where exposure may occur through inhalation, particularly in occupational settings. Our previous work has demonstrated that SWCNT cause robust inflammatory responses in rodents with very early termination of the acute phase and rapid onset of chronic fibrosis. Timely elimination of polymorphonuclear neutrophils (PMNs) through apoptosis and their subsequent clearance by macrophages is a necessary stage in the resolution of pulmonary inflammation whereby NADPH oxidase contributes to control of apoptotic cell death and clearance of PMNs. Thus, we hypothesized that NADPH oxidase may be an important regulator of the transition from the acute inflammation to the chronic fibrotic stage in response to SWCNT. To experimentally address the hypothesis, we employed NADPH oxidase-deficient mice which lack the gp91 phox subunit of the enzymatic complex. We found that NADPH oxidase null mice responded to SWCNT exposure with a marked accumulation of PMNs and elevated levels of apoptotic cells in the lungs, production of pro-inflammatory cytokines, decreased production of the anti-inflammatory and pro-fibrotic cytokine, TGF-β, and significantly lower levels of collagen deposition, as compared to C57BL/6 control mice. These results demonstrate a role for NADPH oxidase-derived reactive oxygen species in determining course of pulmonary response to SWCNT.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>18534653</pmid><doi>10.1016/j.taap.2008.04.018</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-008X
ispartof Toxicology and applied pharmacology, 2008-09, Vol.231 (2), p.235-240
issn 0041-008X
1096-0333
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_563968
source MEDLINE; Elsevier ScienceDirect Journals
subjects 60 APPLIED LIFE SCIENCES
Animals
APOPTOSIS
Apoptosis - drug effects
Biological and medical sciences
CARBON
COLLAGEN
Collagen - drug effects
Collagen - metabolism
Cytokines - drug effects
Cytokines - metabolism
Drug toxicity and drugs side effects treatment
FIBROSIS
Fibrosis - etiology
Fibrosis - metabolism
INFLAMMATION
Inflammation - etiology
Inflammation - pathology
INHALATION
INJURIES
Lung - drug effects
Lung - pathology
Lung disease
Lung Diseases - etiology
Lung Diseases - pathology
LUNGS
LYMPHOKINES
MACROPHAGES
Male
Medical sciences
MICE
Mice, Inbred C57BL
Miscellaneous (drug allergy, mutagens, teratogens...)
NADPH Oxidases - genetics
NADPH Oxidases - metabolism
Nanoparticles
NANOTUBES
Nanotubes, Carbon - toxicity
NEUTROPHILS
Neutrophils - drug effects
Neutrophils - metabolism
Occupational Exposure - adverse effects
OXIDASES
OXIDATION
Oxidative enzymes
Pharmacology. Drug treatments
Pulmonary injury
TOXICITY
Transforming Growth Factor beta - drug effects
Transforming Growth Factor beta - metabolism
title Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T00%3A09%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20accumulation%20of%20neutrophils%20and%20decreased%20fibrosis%20in%20the%20lung%20of%20NADPH%20oxidase-deficient%20C57BL/6%20mice%20exposed%20to%20carbon%20nanotubes&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Shvedova,%20A.A.&rft.date=2008-09-01&rft.volume=231&rft.issue=2&rft.spage=235&rft.epage=240&rft.pages=235-240&rft.issn=0041-008X&rft.eissn=1096-0333&rft.coden=TXAPA9&rft_id=info:doi/10.1016/j.taap.2008.04.018&rft_dat=%3Cproquest_swepu%3E19714208%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19714208&rft_id=info:pmid/18534653&rft_els_id=S0041008X08001890&rfr_iscdi=true